Schedule 13G ownership disclosure
Context Therapeutics, Inc.
Security class unavailable · CUSIP: 21077P108
Event date: 2022-04-28
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 883,654
- Percent of class
- 5.5300%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001387131-22-005868
- Form type
- SC 13G
- Filer
- Affinity Asset Advisors, LLC
- CIK
- CIK 1773195
- Filed
- May 09, 2022
- Reporting period
- Apr 28, 2022
- Description
- Schedule 13G beneficial ownership